EIF2A and cancer: Pharmacologically, treatment with eIF4E anti-sense RNA or agents that induce phosphorylation of eIF2α inhibits translation initiation and proliferation of cancer cells in vitro, and reduces tumor growth in animal models of human cancers [29-31].